YouTube ansehen Info-Reihe Krebs Interviews Interdisziplinäre Behandlung von Gastrointestinalen Tumoren an der MHH Interview mit Prof. Dr. med. Vogel, Klinik für Gastroenterologie, Hepatologie und End
biomarker PIK3CA in tumor pathology]. Lehmann U, Stenzinger A. Pathologie (Heidelb). 2023 Jul;44(4):259-260. doi: 10.1007/s00292-023-01190-9. Epub 2023 Mar 17. [The IDH1/2 biomarker in tumor pathology] Lehmann [...] 07. Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types. Bartels S, Grote I, Wagner M, Boog J, Schipper E, Reineke-Plaass [...] as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor. Boye K, Gorunova L, Gunawan B, Hompland I, Sander B , Panagopoulos I, Langer C, Golas M, Heim S,
Ripperger T: KBG syndrome patient due to 16q24.3 microdeletion presenting with a paratesticular rhabdoid tumor: Coincidence or cancer predisposition? Am J Med Genet A. 2018; 176(6): 1449-1454 Böer-Auer A, Schacht [...] Hartmann C , Samii A, Giese A, Borisov N: Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs. Semin Cancer Biol. 2018; pii: S1044-579X(18)30043-9 [...] Deimling A, Pfister SM, Sahm F, Jones DTW: Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta Neuropathol. 2018;
. Diese Zellen sind von herausragender Bedeutung bei der Abwehr von virusinfizierten Zellen und Tumoren. NK-Zellen benötigen keine Sensibilisierung wie die Vertreter der erworbenen Immunität. Daher können
focused on the development of CAR-engineered T cells to control malignancies such as EBV-associated tumors and is aiming at the development of optimized CAR-strategies for clinical applications. Contact:
Characterization of Molecular and Biological Risk Factors in Mantle Cell Lymphomas Further delineation of tumor suppressor regions on chromosome 1 p22 Final exam November 12th, 2004. Christian Bernreuther GERMANY
-06014-5 * equal contribution Schlüter D, E. Schulz-Niemand, M. Stein, M. Naumann (2022) Ovarian tumor domain proteases in pathogen infection. Trends Microbiol. 30(1): 22-33. doi: 10.1016/j.tim.2021.04
monoclonal antibody MARB8 with unique T-cell-likeproperties to control Epstein-Barr virus-associated tumors. Final exam November 2018 Zulrahman Erlangga INDONESIA Supervisors from 1 June 2016: PD Dr. Florian
ngen Verschiedene Faktoren wie z. B. Infektionen, Störungen des Hormonhaushaltes, Fehlbildungen, Tumore, genetische Erkrankungen oder vorausgegangene Operationen können die Zeugungsfähigkeit des Mannes
Bektas H, Länger F, Piso P, Werner U, Musholt TJ, Lehner F, Becker T, Klempnauer J: Neuroendokrine Tumore des Magens: Chirurgische Therapie und Prognose. Chirurg 2002; 73(4): 331-5 Bock O, Schlué J, Lehmann [...] prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 2002; 73(3): 386-94 Rüdiger T, Höfler H, Kreipe HH, Nizze H, Pfeifer U, Stein H